Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Head & Neck|October 6, 2022
Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancerNicholas Scott-Wittenborn, Gypsyamber D'Souza, Nafi Aygun, et al.
Urologic Oncology|January 21, 2025
Durability of response of UGN-101: Longitudinal follow up of multicenter studySolomon L Woldu, Daniel Igel, Brett Johnson, et al.
The Laryngoscope|January 30, 2024
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell CulturesThomas J Ow, Vikas Mehta, Daniel Li, et al.
Journal of Medical Virology|December 8, 2022
Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methodsDaniel Li, Carlos Thomas, Nitisha Shrivastava, et al.
Anticancer Research|December 6, 2015
Enhanced Systemic Bioavailability of Curcumin Through Transmucosal Administration of a Novel Microgranular FormulationBrian Latimer, Oleksandr Ekshyyan, Neil Nathan, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2026
Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialSheila H Ridner, Derek K Smith, Cristina M Kline-Quiroz, et al.
Urologic Oncology|July 30, 2023
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.
Pageof 25